ACTINIUM PHARMACEUTICALS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2002 | — | — | $-3.2M |
| FY2003 | — | — | $-3.5M |
| FY2004 | — | — | $-5.7M |
| FY2005 | — | — | $-4.6M |
| FY2006 | — | — | $-6.1M |
| FY2007 | — | — | $-5.6M |
| FY2008 | — | — | $-5.6M |
| FY2009 | — | — | $-3.4M |
| FY2010 | $0 | $-26.1K | $-467.3K |
| FY2011 | $0 | $-3.3M | $-3.4M |
| FY2012 | — | $-7.9M | $-8.4M |
| FY2013 | — | $-6.6M | $-10.8M |
| FY2014 | — | $-22.5M | $-24.7M |
| FY2015 | — | $-24.8M | $-21.0M |
| FY2016 | — | $-26.8M | $-24.3M |
| FY2017 | — | $-26.9M | $-26.6M |
| FY2018 | — | $-23.8M | $-23.7M |
| FY2019 | — | $-22.1M | $-21.9M |
| FY2020 | — | $-22.4M | $-22.2M |
| FY2021 | $1.1M | $-25.0M | $-24.8M |
| FY2022 | $1.0M | $-34.1M | $-33.0M |
| FY2023 | $81.0K | $-51.9M | $-48.8M |
| FY2024 | — | $-42.1M | $-38.2M |
| FY2025 | $90.0K | $-36.2M | $-33.9M |